Upregulation of PAI-1 is mediated through TGF-beta/Smad pathway in transplant arteriopathy (Q42525948)

1 November 2017

Upregulation of PAI-1 is mediated through TGF-beta/Smad pathway in transplant arteriopathy (English)

1 reference

Pascal J Goldschmidt-Clermont

1 November 2017

5

object named as

Pascal J Goldschmidt-Clermont

1 reference

1 November 2017

Chunming Dong

1

1 reference

1 November 2017

Shoukang Zhu

2

1 reference

1 November 2017

Tao Wang

3

1 reference

1 November 2017

Woohyun Yoon

4

1 reference

1 November 2017

1 September 2002

1 reference

The Journal of Heart and Lung Transplantation

1 November 2017

1 reference

1 November 2017

21

1 reference

1 November 2017

9

1 reference

1 November 2017

999-1008

1 reference

PDGF receptor inhibition prevents cardiac allograft arteriosclerosis in cholesterol-fed rabbits

1 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

The impact of CD4 and CD8 transendothelial migration in the development of transplant arteriosclerosis following experimental cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

Cardiac allograft vasculopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

Cell-matrix interactions, alteration with aging and age associated diseases. A review

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

Regulation of matrix proteins and impact on vascular structure

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

A pathological role of increased expression of plasminogen activator inhibitor-1 in human or animal disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

The plasminogen activator system: biology and regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

Plasminogen activator inhibitor-1 in patients with ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

Thrombolysis failure: a role for plasminogen activator inhibitor type 1 (PAI-1)

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

Impaired fibrinolysis in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

Effects of human tissue plasminogen gene transfer on allograft coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

Plasminogen-activator inhibitor type 1 and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

Plasminogen activator inhibitor type 1 in ischemic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

Specificity in transforming growth factor beta-induced transcription of the plasminogen activator inhibitor-1 gene: interactions of promoter DNA, transcription factor muE3, and Smad proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

Cooperative binding of Smad proteins to two adjacent DNA elements in the plasminogen activator inhibitor-1 promoter mediates transforming growth factor beta-induced smad-dependent transcriptional activation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

Smads: transcriptional activators of TGF-beta responses

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

Transforming growth factor-beta: association with arteriosclerosis and left ventricular dysfunction after heart transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

Immune sources of transforming growth factor-beta1 reduce transplant arteriosclerosis: insight derived from a knockout mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

Increased plasminogen activator inhibitor-1 and vasculopathy. A reconcilable paradox

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

Impaired arterial neointima formation in mice with disruption of the plasminogen gene

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

Changes in arterial expression of fibrinolytic system proteins in atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: a potential factor predisposing to thrombosis and its persistence.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

Smooth muscle cell apoptosis in arteriosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

CD8+ T lymphocytes mediate destruction of the vascular media in a model of chronic rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

The pathogenesis of cardiac allograft vasculopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

Tolerance induction ameliorates allograft vasculopathy in rat aortic transplants. Influence of Fas-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

TGF-betas and TGF-beta receptors in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

The expression of TGF-beta receptors in human atherosclerosis: evidence for acquired resistance to apoptosis due to receptor imbalance

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

Transforming growth factor beta 1 inhibits fetal lamb ductus arteriosus smooth muscle cell migration.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

PAI-1 secretion and matrix deposition in human peritoneal mesothelial cell cultures: transcriptional regulation by TGF-beta 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

Identification of STRAP, a novel WD domain protein in transforming growth factor-beta signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900403-5

7 January 2021

10.1016/S1053-2498(02)00403-5

Identifiers

DOI

1 reference

1 November 2017

1 reference